Primary Site >> Pancreatic Cancer
Gene >> ERBB3
| 1. | |||||||||||
| Journal: | J Mol Med (Berl). 1996 Jan;74(1):35-42. | ||||||||||
| Title: | Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. | ||||||||||
| Author: | Friess, H|Berberat, P|Schilling, M|Kunz, J|Korc, M|Buchler, M W | ||||||||||
| PMID: | 8834768 | ||||||||||
| 2. | |||||||||||
| Journal: | Ann Surg. 1999 Dec;230(6):767-74; discussion 774-5. | ||||||||||
| Title: | Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. | ||||||||||
| Author: | Friess, H|Wang, L|Zhu, Z|Gerber, R|Schroder, M|Fukuda, A|Zimmermann, A|Korc, M|Buchler, M W | ||||||||||
| PMID: | 10615931 | ||||||||||
| 3. | |||||||||||
| Journal: | J Gastrointest Surg. 2004 Dec;8(8):960-9; discussion 969-70. | ||||||||||
| Title: | Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells. | ||||||||||
| Author: | Arnoletti, J Pablo|Buchsbaum, Donald J|Huang, Zhi-qiang|Hawkins, Ashley E|Khazaeli, Muhamad B|Kraus, Matthias H|Vickers, Selwyn M | ||||||||||
| PMID: | 15585383 | ||||||||||
| 4. | |||||||||||
| Journal: | |||||||||||
| Title: | [(11)C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine | ||||||||||
| Author: | Shan, Liang | ||||||||||
| PMID: | 20641864 | ||||||||||
| 5. | |||||||||||
| Journal: | Cancer Res. 2006 Jan 15;66(2):1025-32. | ||||||||||
| Title: | Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. | ||||||||||
| Author: | Zhang, Yuxiang|Banerjee, Sanjeev|Wang, Zhiwei|Xu, Hu|Zhang, Liyue|Mohammad, Ramzi|Aboukameel, Amro|Adsay, Nazmi V|Che, Mingxin|Abbruzzese, James L|Majumdar, Adhip P N|Sarkar, Fazlul H | ||||||||||
| PMID: | 16424038 | ||||||||||
| 6. | |||||||||||
| Journal: | Int J Cancer. 2007 Feb 1;120(3):514-23. | ||||||||||
| Title: | Expression and differential signaling of heregulins in pancreatic cancer cells. | ||||||||||
| Author: | Kolb, Armin|Kleeff, Jorg|Arnold, Nichole|Giese, Nathalia A|Giese, Thomas|Korc, Murray|Friess, Helmut | ||||||||||
| PMID: | 17096356 | ||||||||||
| 7. | |||||||||||
| Journal: | Cancer Biol Ther. 2007 Apr;6(4):548-54. | ||||||||||
| Title: | ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib. | ||||||||||
| Author: | Frolov, Andrey|Schuller, Kyle|Tzeng, Ching-Wei D|Cannon, Emily E|Ku, Brandon C|Howard, J Harrison|Vickers, Selwyn M|Heslin, Martin J|Buchsbaum, Donald J|Arnoletti, J Pablo | ||||||||||
| PMID: | 17457047 | ||||||||||
| 8. | |||||||||||
| Journal: | Cancer Res. 2007 Aug 1;67(15):7256-65. | ||||||||||
| Title: | Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1. | ||||||||||
| Author: | Lahusen, Tyler|Fereshteh, Mark|Oh, Annabell|Wellstein, Anton|Riegel, Anna T | ||||||||||
| PMID: | 17671194 | ||||||||||
| 9. | |||||||||||
| Journal: | Eur J Surg Oncol. 2009 Oct;35(10):1098-104. | ||||||||||
| Title: | HER-family gene amplification and expression in resected pancreatic cancer. | ||||||||||
| Author: | te Velde, E A|Franke, A C|van Hillegersberg, R|Elshof, S M|de Weger, R W|Borel Rinkes, I H M|van Diest, P J | ||||||||||
| PMID: | 19304440 | ||||||||||
| 10. | |||||||||||
| Journal: | Cancer Sci. 2010 Nov;101(11):2351-60. | ||||||||||
| Title: | Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. | ||||||||||
| Author: | Yotsumoto, Fusanori|Fukami, Tatsuya|Yagi, Hiroshi|Funakoshi, Akihiro|Yoshizato, Toshiyuki|Kuroki, Masahide|Miyamoto, Shingo | ||||||||||
| PMID: | 20726858 | ||||||||||
| 11. | |||||||||||
| Journal: | Cancer Biol Ther. 2010 Sep 15;10(6):555-63. Epub 2010 Sep 30. | ||||||||||
| Title: | ErbB3 expression promotes tumorigenesis in pancreatic adenocarcinoma. | ||||||||||
| Author: | Liles, J Spencer|Arnoletti, Juan Pablo|Tzeng, Ching-Wei D|Howard, J Harrison|Kossenkov, Andrew V|Kulesza, Peter|Heslin, Martin J|Frolov, Andrey | ||||||||||
| PMID: | 20647770 | ||||||||||
| 12. | |||||||||||
| Journal: | Clin Cancer Res. 2010 Feb 1;16(3):912-23. | ||||||||||
| Title: | Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status. | ||||||||||
| Author: | Kimple, Randall J|Vaseva, Angelina V|Cox, Adrienne D|Baerman, Kathryn M|Calvo, Benjamin F|Tepper, Joel E|Shields, Janiel M|Sartor, Carolyn I | ||||||||||
| PMID: | 20103665 | ||||||||||
| 13. | |||||||||||
| Journal: | Exp Cell Res. 2011 Feb 15;317(4):392-404. | ||||||||||
| Title: | Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines. | ||||||||||
| Author: | Mill, Christopher P|Gettinger, Kathleen L|Riese, David J 2nd | ||||||||||
| PMID: | 21110957 | ||||||||||
| 14. | |||||||||||
| Journal: | Br J Cancer. 2011 Aug 9;105(4):523-33. | ||||||||||
| Title: | Targeting ErbB3-mediated stromal-epithelial interactions in pancreatic ductal adenocarcinoma. | ||||||||||
| Author: | Liles, J S|Arnoletti, J P|Kossenkov, A V|Mikhaylina, A|Frost, A R|Kulesza, P|Heslin, M J|Frolov, A | ||||||||||
| PMID: | 21792199 | ||||||||||
| 15. | |||||||||||
| Journal: | Oncology. 2011;81(3-4):192-8. | ||||||||||
| Title: | HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer. | ||||||||||
| Author: | Hirakawa, Toshiki|Nakata, Bunzo|Amano, Ryosuke|Kimura, Kenjiro|Shimizu, Sadatoshi|Ohira, Go|Yamada, Nobuya|Ohira, Masaichi|Hirakawa, Kosei | ||||||||||
| PMID: | 22067729 | ||||||||||
| 16. | |||||||||||
| Journal: | Exp Ther Med. 2011 Sep;2(5):969-975. | ||||||||||
| Title: | Schedule-dependent cytotoxic synergism of pemetrexed and erlotinib in BXPC-3 and PANC-1 human pancreatic cancer cells. | ||||||||||
| Author: | Wang, Lin|Zhu, Zhi-Xia|Zhang, Wen-Ying|Zhang, Wei-Min | ||||||||||
| PMID: | 22977607 | ||||||||||
| 17. | |||||||||||
| Journal: | J Cell Physiol. 2012 Oct;227(10):3381-8. | ||||||||||
| Title: | Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors. | ||||||||||
| Author: | Aurisicchio, Luigi|Marra, Emanuele|Luberto, Laura|Carlomosti, Fabrizio|De Vitis, Claudia|Noto, Alessia|Gunes, Zeynep|Roscilli, Giuseppe|Mesiti, Giuseppe|Mancini, Rita|Alimandi, Maurizio|Ciliberto, Gennaro | ||||||||||
| PMID: | 22213458 | ||||||||||
| 18. | |||||||||||
| Journal: | PLoS One. 2012;7(2):e32232. | ||||||||||
| Title: | The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways. | ||||||||||
| Author: | Jonckheere, Nicolas|Skrypek, Nicolas|Merlin, Johann|Dessein, Anne Frederique|Dumont, Patrick|Leteurtre, Emmanuelle|Harris, Ann|Desseyn, Jean-Luc|Susini, Christiane|Frenois, Frederic|Van Seuningen, Isabelle | ||||||||||
| PMID: | 22393391 | ||||||||||
| 19. | |||||||||||
| Journal: | Curr Drug Targets. 2012 Jun;13(6):802-10. | ||||||||||
| Title: | Targeting EGFR in pancreatic cancer treatment. | ||||||||||
| Author: | Troiani, T|Martinelli, E|Capasso, A|Morgillo, F|Orditura, Michele|De Vita, F|Ciardiello, F | ||||||||||
| PMID: | 22458527 | ||||||||||
| 20. | |||||||||||
| Journal: | PLoS One. 2012;7(6):e39684. | ||||||||||
| Title: | Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer. | ||||||||||
| Author: | Deharvengt, Sophie|Marmarelis, Melina|Korc, Murray | ||||||||||
| PMID: | 22761868 | ||||||||||
| 21. | |||||||||||
| Journal: | J Cancer Res Ther Oncol. 2013 Aug 22;1(1):10. | ||||||||||
| Title: | Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant. | ||||||||||
| Author: | Gallo, Richard M|Bryant, Ianthe N|Mill, Christopher P|Kaverman, Steven|Riese, David J 2nd | ||||||||||
| PMID: | 24791013 | ||||||||||
| 22. | |||||||||||
| Journal: | Mol Cancer Ther. 2013 Oct;12(10):2213-25. | ||||||||||
| Title: | Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinoma. | ||||||||||
| Author: | Mirzoeva, Olga K|Collisson, Eric A|Schaefer, Peter M|Hann, Byron|Hom, Yun K|Ko, Andrew H|Korn, W Michael | ||||||||||
| PMID: | 23918833 | ||||||||||
| 23. | |||||||||||
| Journal: | J Natl Cancer Inst. 2013 Feb 20;105(4):266-73. | ||||||||||
| Title: | HER3 overexpression and survival in solid tumors: a meta-analysis. | ||||||||||
| Author: | Ocana, Alberto|Vera-Badillo, Francisco|Seruga, Bostjan|Templeton, Arnoud|Pandiella, Atanasio|Amir, Eitan | ||||||||||
| PMID: | 23221996 | ||||||||||
| 24. | |||||||||||
| Journal: | PLoS One. 2013;8(1):e53645. | ||||||||||
| Title: | Epithelial-mesenchymal transition markers and HER3 expression are predictors of elisidepsin treatment response in breast and pancreatic cancer cell lines. | ||||||||||
| Author: | Teixido, Cristina|Mares, Roso|Aracil, Miguel|Ramon y Cajal, Santiago|Hernandez-Losa, Javier | ||||||||||
| PMID: | 23320098 | ||||||||||
| 25. | |||||||||||
| Journal: | Pharmacol Res. 2014 Jan;79:34-74. | ||||||||||
| Title: | The ErbB/HER family of protein-tyrosine kinases and cancer. | ||||||||||
| Author: | Roskoski, Robert Jr | ||||||||||
| PMID: | 24269963 | ||||||||||
| 26. | |||||||||||
| Journal: | Exp Cell Res. 2014 Aug 15;326(2):307-14. | ||||||||||
| Title: | Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation. | ||||||||||
| Author: | Stock, Anna-Maria|Hahn, Stephan A|Troost, Gabriele|Niggemann, Bernd|Zanker, Kurt S|Entschladen, Frank | ||||||||||
| PMID: | 24810090 | ||||||||||
| 27. | |||||||||||
| Journal: | Oncogenesis. 2014 Aug 18;3:e117. | ||||||||||
| Title: | Dual targeting of ErbB-2/ErbB-3 results in enhanced antitumor activity in preclinical models of pancreatic cancer. | ||||||||||
| Author: | Ghasemi, R|Rapposelli, I G|Capone, E|Rossi, C|Lattanzio, R|Piantelli, M|Sala, G|Iacobelli, S | ||||||||||
| PMID: | 25133484 | ||||||||||
| 28. | |||||||||||
| Journal: | Oncotarget. 2014 Aug 30;5(16):7138-48. | ||||||||||
| Title: | HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models. | ||||||||||
| Author: | Thomas, Gaelle|Chardes, Thierry|Gaborit, Nadege|Mollevi, Caroline|Leconet, Wilhem|Robert, Bruno|Radosevic-Robin, Nina|Penault-Llorca, Frederique|Gongora, Celine|Colombo, Pierre-Emmanuel|Lazrek, Yassamine|Bras-Goncalves, Rui|Savina, Ariel|Azria, David|Bazi | ||||||||||
| PMID: | 25216528 | ||||||||||
| 29. | |||||||||||
| Journal: | Oncoimmunology. 2014 Dec 21;3(11):e956012. | ||||||||||
| Title: | HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells. | ||||||||||
| Author: | Miller, Megan Jo|Foy, Kevin C|Overholser, Jay P|Nahta, Rita|Kaumaya, Pravin Tp | ||||||||||
| PMID: | 25941588 | ||||||||||
| 30. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):839-44. | ||||||||||
| Title: | Examination of HER3 targeting in cancer using monoclonal antibodies. | ||||||||||
| Author: | Gaborit, Nadege|Abdul-Hai, Ali|Mancini, Maicol|Lindzen, Moshit|Lavi, Sara|Leitner, Orith|Mounier, Lucile|Chentouf, Myriam|Dunoyer, Sai|Ghosh, Manjusha|Larbouret, Christel|Chardes, Thierry|Bazin, Herve|Pelegrin, Andre|Sela, Michael|Yarden, Yosef | ||||||||||
| PMID: | 25564668 | ||||||||||
| 31. | |||||||||||
| Journal: | Oncotarget. 2015 Aug 21;6(24):20132-44. | ||||||||||
| Title: | Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade. | ||||||||||
| Author: | Umelo, Ijeoma Adaku|De Wever, Olivier|Kronenberger, Peter|Van Deun, Jan|Noor, Alfiah|Singh, Kshitiz|Teugels, Erik|Chen, Gang|Bracke, Marc|De Greve, Jacques | ||||||||||
| PMID: | 25992771 | ||||||||||
| 32. | |||||||||||
| Journal: | Oncotarget. 2015 Aug 28;6(25):21085-99. | ||||||||||
| Title: | Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. | ||||||||||
| Author: | Lakshmanan, Imayavaramban|Seshacharyulu, Parthasarathy|Haridas, Dhanya|Rachagani, Satyanarayana|Gupta, Suprit|Joshi, Suhasini|Guda, Chittibabu|Yan, Ying|Jain, Maneesh|Ganti, Apar K|Ponnusamy, Moorthy P|Batra, Surinder K | ||||||||||
| PMID: | 26035354 | ||||||||||
| 33. | |||||||||||
| Journal: | Int J Mol Sci. 2015 Aug 17;16(8):19447-57. | ||||||||||
| Title: | Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma. | ||||||||||
| Author: | Gonzalez-Alonso, Paula|Chamizo, Cristina|Moreno, Victor|Madoz-Gurpide, Juan|Carvajal, Nerea|Daoud, Lina|Zazo, Sandra|Martin-Aparicio, Ester|Cristobal, Ion|Rincon, Raul|Garcia-Foncillas, Jesus|Rojo, Federico | ||||||||||
| PMID: | 26287187 | ||||||||||
| 34. | |||||||||||
| Journal: | Carcinogenesis. 2015 Dec;36(12):1580-9. | ||||||||||
| Title: | The retinoic acid derivative, ABPN, inhibits pancreatic cancer through induction of Nrdp1. | ||||||||||
| Author: | Byun, Sanguine|Shin, Seung Ho|Lee, Eunjung|Lee, Jihoon|Lee, Sung-Young|Farrand, Lee|Jung, Sung Keun|Cho, Yong-Yeon|Um, Soo-Jong|Sin, Hong-Sig|Kwon, Youn-Ja|Zhang, Chengjuan|Tsang, Benjamin K|Bode, Ann M|Lee, Hyong Joo|Lee, Ki Won|Dong, Zigang | ||||||||||
| PMID: | 26464195 | ||||||||||
| 35. | |||||||||||
| Journal: | Expert Opin Biol Ther. 2016;16(2):243-53. | ||||||||||
| Title: | Pertuzumab in gastrointestinal cancer. | ||||||||||
| Author: | Oh, Do-Youn|Bang, Yung-Jue | ||||||||||
| PMID: | 26619359 | ||||||||||
| 36. | |||||||||||
| Journal: | BMC Cancer. 2016 Nov 21;16(1):910. | ||||||||||
| Title: | The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer. | ||||||||||
| Author: | Li, Qin|Zhang, Lei|Li, XiuHong|Yan, Han|Yang, Liuting|Li, Yingying|Li, Teng|Wang, Jing|Cao, Bangwei | ||||||||||
| PMID: | 27871278 | ||||||||||
| 37. | |||||||||||
| Journal: | Pancreas. 2016 Oct;45(9):1263-1271. | ||||||||||
| Title: | MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3. | ||||||||||
| Author: | Feng, Hui|Wang, Yalei|Su, Jiaojiao|Liang, Hongwei|Zhang, Chen-Yu|Chen, Xi|Yao, Weiyan | ||||||||||
| PMID: | 27776045 | ||||||||||
| 38. | |||||||||||
| Journal: | Expert Opin Biol Ther. 2016 Dec;16(12):1549-1555. | ||||||||||
| Title: | The prospect of patritumab for treating non-small cell lung cancer. | ||||||||||
| Author: | Horinouchi, Hidehito | ||||||||||
| PMID: | 27744717 | ||||||||||
| 39. | |||||||||||
| Journal: | Sci Rep. 2016 Sep 9;6:32809. | ||||||||||
| Title: | Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation. | ||||||||||
| Author: | Hao, Jian|Yang, Xue|Ding, Xiu-Li|Guo, Lei-Ming|Zhu, Cui-Hong|Ji, Wei|Zhou, Tong|Wu, Xiong-Zhi | ||||||||||
| PMID: | 27609096 | ||||||||||
| 40. | |||||||||||
| Journal: | PLoS One. 2016 Apr 12;11(4):e0153533. | ||||||||||
| Title: | Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma. | ||||||||||
| Author: | Elebro, Jacob|Heby, Margareta|Warfvinge, Carl Fredrik|Nodin, Bjorn|Eberhard, Jakob|Jirstrom, Karin | ||||||||||
| PMID: | 27070783 | ||||||||||
| 41. | |||||||||||
| Journal: | Target Oncol. 2016 Jun;11(3):371-81. | ||||||||||
| Title: | Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status. | ||||||||||
| Author: | Huguet, Florence|Fernet, Marie|Giocanti, Nicole|Favaudon, Vincent|Larsen, Annette K | ||||||||||
| PMID: | 26668065 | ||||||||||
| 42. | |||||||||||
| Journal: | Mol Cancer Ther. 2017 Jul;16(7):1312-1323. | ||||||||||
| Title: | Neuregulin 1 Allosterically Enhances the Antitumor Effects of the Noncompeting Anti-HER3 Antibody 9F7-F11 by Increasing Its Binding to HER3. | ||||||||||
| Author: | Le Clorennec, Christophe|Bazin, Herve|Dubreuil, Olivier|Larbouret, Christel|Ogier, Charline|Lazrek, Yassamine|Garambois, Veronique|Poul, Marie-Alix|Mondon, Philippe|Barret, Jean-Marc|Mathis, Gerard|Prost, Jean-Francois|Pelegrin, Andre|Chardes, Thierry | ||||||||||
| PMID: | 28507002 | ||||||||||
| 43. | |||||||||||
| Journal: | Clin Cancer Res. 2018 Jun 15;24(12):2873-2885. | ||||||||||
| Title: | Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer. | ||||||||||
| Author: | Camblin, Adam J|Pace, Emily A|Adams, Sharlene|Curley, Michael D|Rimkunas, Victoria|Nie, Lin|Tan, Gege|Bloom, Troy|Iadevaia, Sergio|Baum, Jason|Minx, Charlene|Czibere, Akos|Louis, Chrystal U|Drummond, Daryl C|Nielsen, Ulrik B|Schoeberl, Birgit|Pipas, J Mar | ||||||||||
| PMID: | 29549161 | ||||||||||
| 44. | |||||||||||
| Journal: | Sci Rep. 2018 Jun 13;8(1):9043. | ||||||||||
| Title: | Imaging EGFR and HER3 through (89)Zr-labeled MEHD7945A (Duligotuzumab). | ||||||||||
| Author: | McKnight, Brooke N|Kuda-Wedagedara, Akhila N W|Sevak, Kuntal K|Abdel-Atti, Dalya|Wiesend, Wendy N|Ku, Anson|Selvakumar, Dakshnamurthy|Carlin, Sean D|Lewis, Jason S|Viola-Villegas, Nerissa T | ||||||||||
| PMID: | 29899472 | ||||||||||
| 45. | |||||||||||
| Journal: | Cancer Lett. 2018 Sep 28;432:227-236. | ||||||||||
| Title: | Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer. | ||||||||||
| Author: | Ogier, Charline|Colombo, Pierre-Emmanuel|Bousquet, Corinne|Canterel-Thouennon, Lucile|Sicard, Pierre|Garambois, Veronique|Thomas, Gaelle|Gaborit, Nadege|Jarlier, Marta|Pirot, Nelly|Pugniere, Martine|Vie, Nadia|Gongora, Celine|Martineau, Pierre|Robert, Bru | ||||||||||
| PMID: | 29935372 | ||||||||||
| 46. | |||||||||||
| Journal: | Toxins (Basel). 2018 Oct 31;10(11). pii: toxins10110447. | ||||||||||
| Title: | Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors. | ||||||||||
| Author: | El-Behaedi, Salma|Landsman, Rebekah|Rudloff, Michael|Kolyvas, Emily|Albalawy, Rakan|Zhang, Xianyu|Bera, Tapan|Collins, Keith|Kozlov, Serguei|Alewine, Christine | ||||||||||
| PMID: | 30384408 | ||||||||||